Bactana Corp.

company

About

Bactana develops therapies for pets to treat prediabetes, diabetes and products to reduce antibiotic use during livestock production.

  • 1 - 10

Details

Last Funding Type
Seed
Industries
Agriculture,Animal Feed,Biotechnology,Chemical,Food and Beverage,Health Care,Therapeutics
Founded date
Jan 1, 2017
Number Of Employee
1 - 10
Operating Status
Active

Bactana is a global development stage company at the forefront of identifying and isolating molecules expressed from commensal anaerobic bacteria found in an animal's microbiome. Bactana develops therapies for pets to treat metabolic conditions like prediabetes, diabetes, and other diseases while also developing sustainable products to reduce the use of antibiotics and natural resources during livestock production.

It was founded in 2017 and is headquartered in Farmington, Connecticut.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
3
$1.60M
Bactana Corp. has raised a total of $1.60M in funding over 2 rounds. Their latest funding was raised on Feb 18, 2022 from a Grant round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Feb 18, 2022 Grant $256K 1 National Science Foundation Detail
Jan 22, 2019 Series A $1.34M 1 Detail
Mar 29, 2017 Seed 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
2
Bactana Corp. is funded by 2 investors. National Science Foundation and Sustainable Income Capital Management are the most recent investors.
Investor Name Lead Investor Funding Round
National Science Foundation Yes Grant
Sustainable Income Capital Management Series A